Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 2,206,407 7.600% | -164,868 (-6.95%) | Filing History |
| 2023-02-10 7:28 pm Purchase | 2023-02-10 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 2,450,000 8.400% | 950,000 (+63.33%) | Filing History |
| 2022-10-05 5:00 pm Purchase | 2022-10-03 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,377,090 11.600% | 14,630 (+0.44%) | Filing History |
| 2022-04-05 5:15 pm Purchase | 2022-03-29 | 13D | IGM Biosciences, Inc. IGMS | BAKER BROS. ADVISORS LP | 3,169,894 11.600% | 12,110 (+0.38%) | Filing History |
| 2022-04-05 5:09 pm Sale | 2022-04-01 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group, LLC | 3,362,460 12.900% | -75,572 (-2.20%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 2,371,275 9.100% | 1,042,491 (+78.45%) | Filing History |
| 2022-02-11 06:38 am Purchase | 2022-02-11 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 1,500,000 5.800% | 175,000 (+13.21%) | Filing History |
| 2021-09-27 5:22 pm Purchase | 2021-09-16 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 1,325,000 5.200% | 1,325,000 (New Position) | Filing History |
| 2021-02-16 12:24 pm Purchase | 2020-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 1,328,784 5.200% | 1,328,784 (New Position) | Filing History |
| 2021-02-11 1:46 pm Sale | 2020-12-31 | 13G | IGM Biosciences, Inc. IGMS | JANUS HENDERSON GROUP PLC JHG | 501,745 1.600% | -1,022,017 (-67.07%) | Filing History |
| 2021-01-29 5:03 pm Purchase | 2021-01-23 | 13D | IGM Biosciences, Inc. IGMS | BAKER BROS. ADVISORS LP | 3,157,784 12.400% | 513 (+0.02%) | Filing History |
| 2021-01-05 5:14 pm Sale | 2021-01-05 | 13D | IGM Biosciences, Inc. IGMS | BAKER BROS. ADVISORS LP | 3,157,271 12.400% | -35,751 (-1.12%) | Filing History |